Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Graner

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Oral Diseases|October 26, 2011
Cleidocranial dysplasia: oral features and genetic analysis of 11 patientsA Bufalino, L M R Paranaíba, A F Gouvêa, et al.
Brain Research. Molecular Brain Research|March 17, 2000
Cellular prion protein binds laminin and mediates neuritogenesisE Graner, A F Mercadante, S M Zanata, et al.
Journal of the American Medical Directors Association|December 30, 2008
Oropharyngeal dysphagia assessment and treatment efficacy: setting the record straight (response to Campbell-Taylor)James L Coyle, Lori A Davis, Caryn Easterling, et al.
Nature Metabolism|June 2, 2022
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolismF Chen, W A M Elgaher, M Winterhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Dysphagia|October 27, 2009
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal diseaseJudith McElhiney, Matthew R Lohse, Amindra S Arora, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Oral Diseases|October 26, 2011
Cleidocranial dysplasia: oral features and genetic analysis of 11 patientsA Bufalino, L M R Paranaíba, A F Gouvêa, et al.
Brain Research. Molecular Brain Research|March 17, 2000
Cellular prion protein binds laminin and mediates neuritogenesisE Graner, A F Mercadante, S M Zanata, et al.
Journal of the American Medical Directors Association|December 30, 2008
Oropharyngeal dysphagia assessment and treatment efficacy: setting the record straight (response to Campbell-Taylor)James L Coyle, Lori A Davis, Caryn Easterling, et al.
Nature Metabolism|June 2, 2022
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolismF Chen, W A M Elgaher, M Winterhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Dysphagia|October 27, 2009
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal diseaseJudith McElhiney, Matthew R Lohse, Amindra S Arora, et al.
Pageof 5